|
|
| ÂÒ | 11 |  | 5.85 |
| ÇÔ¸Õ¹íÒà¢éÒÂÒ | 5 | | 2.66 |
| ¡ÃзÃǧÊÒ¸ÒóÊØ¢¡Ãا෾ ÊÓÃǨÊÒúÍáá«ìã¹µÅÒ´ | 4 | | 2.13 |
| ÂÒÅÐÅÒÂÅÔèÁàÅ×Í´ | 4 | | 2.13 |
| ˹èǧҹ·ÕèÃѺ¼Ô´ªÍºÍÒËÒÃáÅÐÂÒèѧËÇÑ´ÀÙà¡çµ | 3 | | 1.60 |
| ÂÒá¡éËÇÑ´ | 3 | | 1.60 |
| ˹ѧÊ×Í´ÙáŵÑÇàͧµÒÁ¹ÒÌÔ¡ÒÃèÒ§¡Ò | 3 | | 1.60 |
| ÂÒʵÃÕÊÔ§àË | 3 | | 1.60 |
| swot ¡ÒúԹä·Â | 3 | | 1.60 |
| Ãкºelib | 3 | | 1.60 |
| ¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ | 3 | | 1.60 |
| fda moph go th | 2 | | 1.06 |
| ¾ÅÒʵԡ | 2 | | 1.06 |
| ÂÒ¹éíÒÊÁعä¾ÃâËÂè§àËÔ§ | 2 | | 1.06 |
| â·É¢Í§ãº¡ÃзèÍÁ | 2 | | 1.06 |
| ÂÒÅÐÅÒÂàÅ×Í´ | 2 | | 1.06 |
| Ëéͧ·Ó¹éÓ´×èÁ·Õè¼èҹ͠| 2 | | 1.06 |
| »ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢ ©ºÑº·Õè 84 ¾.È.2527 | 2 | | 1.06 |
| ¡ÒâÖé¹·ÐàºÕ¹ÍÒËÒÃáÅÐÂÒ | 2 | | 1.06 |
| ÂÒÇÒÃì¿ÒÃÔ¹ | 2 | | 1.06 |
| ¼ÅÔµÀѳ±ìÍÒËÒÃà¾×èÍàÈÃÉ°¡Ô¨ | 2 | | 1.06 |
| ʶԵÔáÊ´§¨Ó¹Ç¹Ê¶Ò¹·Õè¼ÅÔµÂÒá¼¹âºÃÒ³ | 2 | | 1.06 |
| ÊÓà¾ç§à¤Ã×èͧÊÓÍÒ§»ÅÍÁ | 2 | | 1.06 |
| ¢Ñ鹵͹¡ÒâÖé¹·ÐàºÕ¹Í | 2 | | 1.06 |
| ·íÒà¢ÕéÂÇ»ÅÍÁ | 1 | | 0.53 |
| ÂÒÊѵÇ쵡¤éÒ§ã¹à¹×éÍÊѵÇì | 1 | | 0.53 |
| Ë.¨.¡.á͹¹Ò¤ÍÊàÁµÔ¡Êì 2004 | 1 | | 0.53 |
| «Ù¤ÃÒâÅÊ ¤×Í | 1 | | 0.53 |
| ¡ÒÃà»ÃÕºà·Õº¼ÅÔµÀѳ±ìÍÒËÒÃáÅÐÂÒ | 1 | | 0.53 |
| update on the ongoing outbreak of haemolytic uremic syndrom | 1 | | 0.53 |
| ¡ÒâÖé¹·ÐàºÕ¹ | 1 | | 0.53 |
| ÊÃþ¤Ø³ÂÒʵÃÕ¹ÔÊÔ§àËËÁÍÁÕ | 1 | | 0.53 |
| how to run a drugstore business | 1 | | 0.53 |
| ÍÒËÒÃáÅÐÂÒ¡ÃзÃǧÊÒ¸ÒóÊØ¢ | 1 | | 0.53 |
| ¢Í¤ÇÒÁÃÙéàÃ×èͧ¢ÒÂà¤Ã×èͧÊÓÍÒ§ | 1 | | 0.53 |
| ÂÒá¡ä¢éËÇÑ´ãËè | 1 | | 0.53 |
| ¡ÒáԹÂҪش | 1 | | 0.53 |
| lecithin ¤×Í | 1 | | 0.53 |
| àÊ鹡ëÇÂàµÕëÂÇ ¡ÃÁÇÔ·ÂÒÈÒʵÃì | 1 | | 0.53 |
| ¹Á¼§´Ñ´á»Å§ àÍÊ -26 | 1 | | 0.53 |
| ÂÒ ÊµÃÕ ºÑÇ á¡éÇ ÊÃþ¤Ø³ | 1 | | 0.53 |
| ªØ´¹Ñ¡àÃÕ¹ âçàÃÕ¹ÁÒÃÕÇÔ·ÂÒ ¡ºÔ¹ | 1 | | 0.53 |
| ¢èÒÇà¡ÕèÂǡѺͧ¡ÒÃÍÒËÒÃáÅÐÂÒ | 1 | | 0.53 |
| ¢Ñ鹵͹¡Òè´·ÐàºÕ¹ Í | 1 | | 0.53 |
| ÂÒʵÃÕ¹ÔÊÔ§àËËÁÍÁÕ | 1 | | 0.53 |
| ÍǪ á¾·Âì | 1 | | 0.53 |
| ¨Ø´Íè͹¢Í§ºÃÔÉÑ·¡ÒúԹä·Â | 1 | | 0.53 |
| ¤é¹ËÒ˹ѧÊ×Íà·ÕèÂÇàÁ×ͧ¹Ã¡©ºÑº¤ÃºÃͺ15»Õ˹éÒ263¶Ö§264 | 1 | | 0.53 |
| ÊÒ¸ÒóÊØ¢ÍÓ¹Ò¨à¨ÃÔ áºº¿ÍÃìÁ¡ÒÃÊÓÃǨÁÐàÃç§àµéÒ¹Á | 1 | | 0.53 |
| Ãкºhaccp㹡ÒäǺ¤ØÁÍÒËÒÃáªèá¢ç§ | 1 | | 0.53 |
| ÇÔ¸ÕÊ׺¤é¹¢éÍÁÙÅ˹ѧÊ×ÍẺ online | 1 | | 0.53 |
| »ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢ ©ºÑº·Õè ñóõ(¾.È.òõóù) | 1 | | 0.53 |
| ¹éÓáÃè·Õè¼èÒ¹¡ÒÃÃѺÃͧ¨Ò¡ ÍÂ. | 1 | | 0.53 |
| ¢¹Ò´ÂÒ aspirin ã¹¼ÙéãËè | 1 | | 0.53 |
| âÍ¡ÒÈ ¢Í§ºÃÔÉÑ·¡ÒúԹä·Â 㹡ÒÃÇÔà¤ÃÒÐËì swot | 1 | | 0.53 |
| ÍÒËÒÃà»ç¹¾ÔÉ âçàÃÕ¹ä·Ã¹éÍ | 1 | | 0.53 |
| ¾ÒÇàÇÍÃì¾Í ÂÒàʾµÔ´áÅк·Å§â·É | 1 | | 0.53 |
| ¹éÓ´×èÁ¡ÃÐáÊÊÔ¹¸ì | 1 | | 0.53 |
| ÂÒá¼¹âºÃÒ³ âËÂè§àËÔ§ | 1 | | 0.53 |
| »ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢ ©ºÑº·Õè 21 | 1 | | 0.53 |
| »ÅÒ´Ôº+«ÙªÔ+ÍѹµÃÒ | 1 | | 0.53 |
| ÂÒʵÃÕູâÅ á¡éÊÔÇ | 1 | | 0.53 |
| ¡ÒÃáÊ´§¢éÍÁÙÅʶԵԼÅÔµÀѳ | 1 | | 0.53 |
| ¢èÒÇà¡ÕèÂǡѺÍ | 1 | | 0.53 |
| ¼èҵѴµÕ¹¡ÒáÅС¤ÔéÇ | 1 | | 0.53 |
| ÂÒ¡ÅØÁ൵ÃéÒ | 1 | | 0.53 |
| ¹È.ÃÒÁ ¨Õé sizzler ËÒ´ãËè¨èÒ 2 ÅéÒ¹ | 1 | | 0.53 |
| âËÂè§ àËÔ § ÊÃþ¤Ø³ | 1 | | 0.53 |
| ÍÂ. | 1 | | 0.53 |
| ¡ÒÃÇÔà¤ÃÒÐËì¡ÒúԹä·Â | 1 | | 0.53 |
| ã¤Ãà¤Â¡Ô¹ÂÒʵÃÕËÁÍÁÕp | 1 | | 0.53 |
| ÂÒ¹éíÒʵÃÕà¾çÀÒ¤ ÊÃþ¤Ø³ | 1 | | 0.53 |
| ÇÔ¸Õ¡ÒÃÊ׺¤é¹¢éÍÁÙÅËéͧÊÁØ´ | 1 | | 0.53 |
| ¾.¹ÒÃҾà | 1 | | 0.53 |
| dsp ͧ¤ì¡ÒÃàÀÊѪ | 1 | | 0.53 |
| ÂÒÊáµµÔ¹ (nystatin) | 1 | | 0.53 |
| ¡ÒÃì«Õà¹Õ ¾ÅÑÊ ÍѹµÃÒ | 1 | | 0.53 |
| »ÃСÒÈ ÍÂ. àÃ×èͧ«Ù´Õà¿´ÃÕ¹ | 1 | | 0.53 |
| ÍѹµÃÒ¨ҡ¡ÒÃãªéÂҪشá¡éàÁ×èÍ | 1 | | 0.53 |
| ˹ѧÊ×Í ¤ÍàÅÊàµÍÃÍÅ | 1 | | 0.53 |
| ˹ѧÊ×ÍãËÁè | 1 | | 0.53 |
| ÅÙ¡àËÁç¹ | 1 | | 0.53 |
| â·É¢Í§¡ÒôÁ¡ÒÇ | 1 | | 0.53 |
| swot ¡ÒúԹä·Â ¨Ó¡Ñ´ | 1 | | 0.53 |
| ÇÔ¸Õ·Óà¹Â¶ÑèÇ | 1 | | 0.53 |
| »ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢©ºÑº·Õè301 | 1 | | 0.53 |
| ÇÔà¤ÃÒÐËì swot ¡ÒúԹä·Â | 1 | | 0.53 |
| ¡ÅØèÁÂÒ ä·áÍÁ࿹ԤÍÅ | 1 | | 0.53 |
| ÇÔà¤ÃÒÐËì pest ¢Í§·èÒÍÒ¡ÒÈÂÒ¹ä·Â | 1 | | 0.53 |
| swot à¤Ã×èͧÁ×Íá¾·Âì | 1 | | 0.53 |
| swot ¢Í§ºÃÔÉÑ·¡ÒúԹä·Â | 1 | | 0.53 |
| ¨ÃÔ¸ÃÃÁ äºàÍÍÃìÊ´êÍÿ | 1 | | 0.53 |
| ͧ¤ì¡ÒÃÍÒËÒÃáÅÐÂÒ á¼¹·Õè | 1 | | 0.53 |
| ÊÙµÃà¹Â¶ÑèÇ | 1 | | 0.53 |
| midazolam ÂÒ | 1 | | 0.53 |
| ࿹ÔźٷÒ⫹ | 1 | | 0.53 |
| ËÂØ´¨Í¿éÒ | 1 | | 0.53 |
| âÍ¡ÒÊáÅÐÍØ»ÊÃä¢Í§¡ÒúԹä·Â | 1 | | 0.53 |
| ª×èÍÂÒá¡é»Ç´ à»ç¹ä¢é | 1 | | 0.53 |
| ÇÔ¸Õ·íÒáÍÅ¡ÍÎÍÅì¨Ø´ä¿ | 1 | | 0.53 |
,
User's Guide
˹éÒÅçÍ¡ÍÔ¹| ʶԵÔÃÒ»Õ
| ʶԵÔÃÒÂà´×͹
| ʶԵÔÃÒÂÇѹ
| ʶԵÔÃÒªÑèÇâÁ§
| Eng
Pageview 
Unique IPs 
Sessions